Western Pacific: Countries and territories across the region continue to report COVID-19 disease activity as of June 1. /update 13

Event

Several countries and territories in the Western Pacific continue to report COVID-19 transmission as of June 1. According to WHO data through June 1, the following countries and territories in the Western Pacific have identified disease activity and/or confirmed COVID-19 cases:

No cases

• Solomon Islands: 18 cases (The last case reported: Feb. 8, 2021)

• Samoa: 4 cases (The last case reported: Feb. 13, 2021)

• Marshall Islands: 4 cases (The last case reported: Nov. 17, 2020)

• Vanuatu: 3 cases (The last case reported: March 8, 2021)

Sporadic cases

• Singapore: 62,069 cases

• Cambodia: 30,710 cases

• French Polynesia: 18,870 cases

• New Zealand: 2,673 cases

• Laos: 1,912 cases

• Fiji: 464 cases*

• Wallis and Futuna: 445 cases

• Brunei Darussalam: 242 cases

• New Caledonia: 128 cases*

Clusters of cases

• Japan: 744,487 cases

• South Korea: 140,799 cases

• Australia: 30,117 cases

• Hong Kong SAR: 11,842 cases

• Taiwan: 8,842 cases*

• Guam: 7,795 cases

• Vietnam: 7,482 cases*

• Macau SAR: 51 cases

Community transmission

• Philippines: 1,235,467 cases

• Malaysia: 572,357 cases*

• Papua New Guinea: 15,910 cases

Pending

• Northern Mariana Islands: 168 cases

*As of June 1, active cases in the country are increasing.

Context

COVID-19 is a viral respiratory disease caused by infection with the SARS-CoV-2 virus. Human-to-human transmission does occur, primarily through respiratory droplets from infected individuals or contact with contaminated surfaces or objects. Symptoms occur 1-14 days following exposure (average of 3-7 days). These symptoms typically include fever, fatigue, and dry cough; less common symptoms include headache, diarrhea, loss of taste or smell, reddening of the eyes, skin rash, or discoloration of the fingers or toes. Symptoms may worsen to difficulty breathing, pneumonia, and organ failure - especially in those with underlying, chronic medical conditions. Some infected individuals display no symptoms. Multiple variants of COVID-19 have been identified globally, some of which spread more easily between people. COVID-19 vaccines are being distributed to frontline workers and the elderly in some countries, while other vaccines are in varying stages of development and clinical trials; more data is required to determine the efficacy of vaccines against COVID-19 variants.

Older individuals and people of any age with chronic medical conditions or compromised immunity should consider postponing nonessential travel, including domestic travel, and take special precautions to avoid becoming ill, especially where sustained community transmission of COVID-19 is ongoing. All individuals should monitor their health and limit interactions with others for 14 days after returning from travel.

Advice

Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.

Resources

WHO coronavirus knowledge base
WHO: Public health considerations while resuming international travel
US CDC: Guidance for Businesses and Workplaces
US CDC: Preventing COVID-19 Spread in Communities
Mental Health Considerations during COVID-19 Outbreak
US CDC: Manage Anxiety and Stress
New England Journal of Medicine: COVID-19 FAQs